News

GEN - Genetic Engineering and Biotechnology News9h

3 BLAs in 3 Years: Ocugen Sees Potential in Eye Disease Gene Therapies

Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Incyte Announces Departure of Chief Financial Officer Christiana Stamoulis

Incyte (Nasdaq:INCY) today announced that Christiana Stamoulis will step down from her role as Executive Vice President and ...

‘We will work collaboratively’: Big Pharma admits it is discussing Trump’s plan to lower drug prices

Pfizer CEO says drugmakers ‘are all ready to roll up their sleeves and execute’ as president demands more direct-to-consumer options ...
Precision Medicine Online16h

4D Molecular Therapeutics Reaches Agreement With EMA on Regulatory Path for DME Gene Therapy

The regulator is allowing the firm to submit data on 4D-150 from a single Phase III trial and draw on readouts from previously conducted studies in wet AMD.
PMLive20h

Solving the patient engagement value equation

But while an improved reputation can be a by-product of patient engagement, it should not be the driving force behind it.